BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krings G, Ramachandran R, Jain D, Wu TT, Yeh MM, Torbenson M, Kakar S. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol. 2013;26:782-791. [PMID: 23348905 DOI: 10.1038/modpathol.2012.243] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 O’connor K, Walsh JC, Schaeffer DF. Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity. Annals of Hepatology 2014;13:317-22. [DOI: 10.1016/s1665-2681(19)30859-2] [Cited by in Crossref: 33] [Article Influence: 4.7] [Reference Citation Analysis]
2 Zhang L, Frank R, Furth EE, Ziober AF, LiVolsi VA, Zhang PJ. Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma. Exp Hematol Oncol 2014;3:12. [PMID: 24860692 DOI: 10.1186/2162-3619-3-12] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Hochstedler CM, Leidinger MR, Maher-Sturm MT, Gibson-Corley KN, Meyerholz DK. Immunohistochemical detection of arginase-I expression in formalin-fixed lung and other tissues. J Histotechnol 2013;36:128-34. [PMID: 25332513 DOI: 10.1179/2046023613Y.0000000032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
4 Samdanci ET, Akatli AN, Soylu NK. Clinicopathological Features of Two Extremely Rare Hepatocellular Carcinoma Variants: a Brief Review of Fibrolamellar and Scirrhous Hepatocellular Carcinoma. J Gastrointest Cancer 2020;51:1187-92. [PMID: 32860202 DOI: 10.1007/s12029-020-00500-1] [Reference Citation Analysis]
5 Misdraji J, Centeno BA, Pitman MB. Ancillary tests in the diagnosis of liver and pancreatic neoplasms. Cancer Cytopathology 2018;126:672-90. [DOI: 10.1002/cncy.22009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Menz A, Bauer R, Kluth M, Marie von Bargen C, Gorbokon N, Viehweger F, Lennartz M, Völkl C, Fraune C, Uhlig R, Hube-Magg C, De Wispelaere N, Minner S, Sauter G, Kind S, Simon R, Burandt E, Clauditz T, Lebok P, Jacobsen F, Steurer S, Wilczak W, Krech T, Marx AH, Bernreuther C. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors. Hum Pathol 2021;115:19-36. [PMID: 34102222 DOI: 10.1016/j.humpath.2021.05.012] [Reference Citation Analysis]
7 El Jabbour T, Lagana SM, Lee H. Update on hepatocellular carcinoma: Pathologists’ review. World J Gastroenterol 2019; 25(14): 1653-1665 [PMID: 31011252 DOI: 10.3748/wjg.v25.i14.1653] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 34] [Article Influence: 18.0] [Reference Citation Analysis]
8 Shahid M, Mubeen A, Tse J, Kakar S, Bateman AC, Borger D, Rivera MN, Ting DT, Deshpande V. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: Evaluation of manual and automated in situ hybridization platforms. Am J Surg Pathol. 2015;39:25-34. [PMID: 25353287 DOI: 10.1097/pas.0000000000000343] [Cited by in Crossref: 45] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
9 Chen DA, Koehne de Gonzalez A, Fazlollahi L, Coffey A, Remotti HE, Lagana SM. In situ hybridisation for albumin RNA in paediatric liver cancers compared with common immunohistochemical markers. J Clin Pathol 2021;74:98-101. [PMID: 32471888 DOI: 10.1136/jclinpath-2020-206663] [Reference Citation Analysis]
10 Takahashi Y, Dungubat E, Kusano H, Ganbat D, Tomita Y, Odgerel S, Fukusato T. Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors. Int J Mol Sci 2021;22:5780. [PMID: 34071338 DOI: 10.3390/ijms22115780] [Reference Citation Analysis]
11 Choi WT, Kakar S. Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma. Gastroenterol Clin North Am. 2017;46:311-325. [PMID: 28506367 DOI: 10.1016/j.gtc.2017.01.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
12 Ferrell LD, Kakar S, Terracciano LM, Wee A. Tumours and Tumour-like Lesions of the Liver. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 780-879. [DOI: 10.1016/b978-0-7020-6697-9.00013-3] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Mann SA, Saxena R. Differential diagnosis of epithelioid and clear cell tumors in the liver. Seminars in Diagnostic Pathology 2017;34:183-91. [DOI: 10.1053/j.semdp.2016.12.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Clark I, Shah SS, Moreira R, Graham RP, Wu T, Torbenson MS, Chandan V. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative. Human Pathology 2017;69:90-5. [DOI: 10.1016/j.humpath.2017.09.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
15 Matsukuma KE, Yeh MM. Update on the pathology of liver neoplasms. Ann Diagn Pathol. 2019;38:126-137. [PMID: 30597357 DOI: 10.1016/j.anndiagpath.2018.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Choi WT, Ramachandran R, Kakar S. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. Hum Pathol. 2017;63:1-13. [PMID: 28087475 DOI: 10.1016/j.humpath.2016.12.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
17 Wang J, Dong R, Zheng S. Circulating Epithelial Cells in Patients With Liver Disease. Gastroenterology 2019;156:1932. [PMID: 30771356 DOI: 10.1053/j.gastro.2018.10.062] [Reference Citation Analysis]
18 Agni RM. Diagnostic histopathology of hepatocellular carcinoma: A case-based review. Semin Diagn Pathol. 2017;34:126-137. [PMID: 28143798 DOI: 10.1053/j.semdp.2016.12.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
19 Jiang K, Al-Diffhala S, Centeno BA. Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification. Cancer Control. 2018;25:1073274817744625. [PMID: 29350068 DOI: 10.1177/1073274817744625] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
20 Pittman ME, Brunt EM. Anatomic pathology of hepatocellular carcinoma: histopathology using classic and new diagnostic tools. Clin Liver Dis. 2015;19:239-259. [PMID: 25921661 DOI: 10.1016/j.cld.2015.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
21 Brunt EM, Paradis V, Sempoux C, Theise ND. Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. Hepat Oncol 2015;2:255-73. [PMID: 30191007 DOI: 10.2217/hep.15.8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
22 Koehne de Gonzalez AK, Salomao MA, Lagana SM. Current concepts in the immunohistochemical evaluation of liver tumors. World J Hepatol 2015; 7(10): 1403-1411 [PMID: 26052385 DOI: 10.4254/wjh.v7.i10.1403] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
23 Vij M, Calderaro J. Pathologic and molecular features of hepatocellular carcinoma: An update. World J Hepatol 2021; 13(4): 393-410 [PMID: 33959223 DOI: 10.4254/wjh.v13.i4.393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Torbenson MS. Hepatocellular Carcinoma. In: Mounajjed T, Chandan VS, Torbenson MS, editors. Surgical Pathology of Liver Tumors. Cham: Springer International Publishing; 2015. pp. 169-218. [DOI: 10.1007/978-3-319-16089-4_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Sarcognato S, Sacchi D, Fassan M, Fabris L, Cadamuro M, Zanus G, Cataldo I, Capelli P, Baciorri F, Cacciatore M, Guido M. Cholangiocarcinoma. Pathologica 2021;113:158-69. [PMID: 34294934 DOI: 10.32074/1591-951X-252] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Chan JKC. Newly Available Antibodies With Practical Applications in Surgical Pathology. Int J Surg Pathol 2013;21:553-72. [DOI: 10.1177/1066896913507601] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
27 Vyas M, Zhang X. Hepatocellular Carcinoma. Clinics in Liver Disease 2020;24:591-610. [DOI: 10.1016/j.cld.2020.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Labib OH, Harb OA, Khalil OH, Baiomy TA, Gertallah LM, Ahmed RZ. The Diagnostic Value of Arginase-1, FTCD, and MOC-31 Expression in Early Detection of Hepatocellular Carcinoma (HCC) and in Differentiation Between HCC and Metastatic Adenocarcinoma to the Liver. J Gastrointest Canc 2020;51:88-101. [DOI: 10.1007/s12029-019-00211-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
29 Mathew S, Ali A, Abdel-hafiz H, Fatima K, Suhail M, Archunan G, Begum N, Jahangir S, Ilyas M, Chaudhary AG, Al Qahtani M, Mohamad Bazarah S, Qadri I. Biomarkers for virus-induced hepatocellular carcinoma (HCC). Infection, Genetics and Evolution 2014;26:327-39. [DOI: 10.1016/j.meegid.2014.06.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
30 Koehne de Gonzalez A, Lagana SM. Update on Ancillary Testing in the Evaluation of High-Grade Liver Tumors. Surg Pathol Clin. 2018;11:367-375. [PMID: 29751880 DOI: 10.1016/j.path.2018.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
31 Yeh MM, Yeung RS, Apisarnthanarax S, Bhattacharya R, Cuevas C, Harris WP, Hon TLK, Padia SA, Park JO, Riggle KM, Daoud SS. Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience. World J Hepatol 2015; 7(11): 1460-1483 [PMID: 26085907 DOI: 10.4254/wjh.v7.i11.1460] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
32 Fujikura K, Yamasaki T, Otani K, Kanzawa M, Fukumoto T, Ku Y, Hirose T, Itoh T, Zen Y. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas. Am J Surg Pathol 2016;40:689-96. [PMID: 26735860 DOI: 10.1097/PAS.0000000000000585] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 4.2] [Reference Citation Analysis]
33 Geramizadeh B, Seirfar N. Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver. Hepat Mon 2015;15:e30336. [PMID: 26300935 DOI: 10.5812/hepatmon30336v2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
34 Torbenson MS. Morphologic Subtypes of Hepatocellular Carcinoma. Gastroenterol Clin North Am. 2017;46:365-391. [PMID: 28506370 DOI: 10.1016/j.gtc.2017.01.009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 14.7] [Reference Citation Analysis]